Association between osteoarthritis and cardiovascular disease: Systematic review and meta-analysis

European Journal of Preventive Cardiology

Volumn 23, Issue 9, 2016, Pages 938-946

  Hall, Andrew J ^a   Stubbs, Brendon ^b   Mamas, Mamas A ^c   Myint, Phyo K ^a   Smith, Toby O ^d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

cardiovascular disease; cerebrovascular disease; hypertension; myocardial infarction; Osteoarthritis

Indexed keywords

CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; META ANALYSIS; OSTEOARTHRITIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; CHI SQUARE DISTRIBUTION; INCIDENCE; ODDS RATIO; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; HUMANS; INCIDENCE; ODDS RATIO; OSTEOARTHRITIS; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84966784629     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487315610663     Document Type: Review

References (46)

1. Osgood E, Trudeau JJ, Eaton TA, et al. Development of a bedside pain assessment kit for the classification of patients with osteoarthritis. Rheumatol Int 2015; 35: 1005-1013.
2. Gelber AC,. In the clinic. Osteoarthritis. Ann Intern Med 2014; 161: ITC1-ITC16.
3. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163-2196.
4. Turkiewicz A, Petersson IF, Björk J, et al. Current and future impact of osteoarthritis on health care: A population-based study with projections to year 2032. Osteoarthritis Cartilage 2014; 22: 1826-1832.
5. World Health Organisation. Cardiovascular disease. Data and statistics, http://www.euro.who.int/en/health-topics/noncommunicable-diseases/cardiovascular-diseases/data-and-statistics (2015, accessed 5 January 2015).
6. Ryan CG, McDonough S, Kirwan JP, et al. An investigation of association between chronic musculoskeletal pain and cardiovascular disease in the Health Survey for England (2008). Eur J Pain 2014; 18: 740-750.
7. Goodson NJ, Smith BH, Hocking LJ, et al. Cardiovascular risk factors associated with the metabolic syndrome are more prevalent in people reporting chronic pain: Results from a cross-sectional general population study. Pain 2013; 154: 1595-1602.
8. Kerkhoff AC, Moreira LB, Fuchs FD, et al. Association between hypertension and musculoskeletal complaints: A population-based study. J Hypertens 2012; 30: 2112-2117.
9. Bag-Ozbek A, Giles JT,. Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: Is there a paradoxical relationship? Curr Allergy Asthma Rep 2015; 15: 497-497.
10. van der Burg LR, Boonen A, van Amelsvoort LG, et al. Effects of cardiovascular comorbidities on work participation in rheumatic diseases: A prospective cohort study among working individuals. Arthritis Care Res 2014; 66: 157-163.
11. Ha IH, Lee J, Kim MR, Kim H, et al. The association between the history of cardiovascular diseases and chronic low back pain in South Koreans: A cross-sectional study. PLoS One 2014; 9: e93671-e93671.
12. Erb N, Pace AV, Douglas KM, et al. Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2004; 33: 293-299.
13. Chapple CM, Nicholson H, Baxter GD, et al. Patient characteristics that predict progression of knee osteoarthritis: A systematic review of prognostic studies. Arthritis Care Res 2011; 63: 1115-1125.
14. Belo JN, Berger MY, Reijman M, et al. Prognostic factors of progression of osteoarthritis of the knee: A systematic review of observational studies. Arthritis Rheum 2007; 57: 13-26.
15. Iannone F, Lapadula G,. Obesity and inflammation-targets for OA therapy. Curr Drug Targets 2010; 11: 586-598.
16. Findlay DM. Cascular pathology and osteoarthritis. Rheumatology 207; 46: 1763-1768.
17. Han CD, Yang IH, Lee WS, et al. Correlation between metabolic syndrome and knee osteoarthritis: Data from the Korean National Health and Nutrition Examination Survey (KNHANES). BMC Public Health 2013; 13: 603-603.
18. van Rooy MJ, Pretorius E,. Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events. Curr Med Chem 2014; 21: 2121-2129.
19. Moher D, Liberati A, Tetzlaff J, et al.PRISMA Group,. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol 2009; 62: 1006-1012.
20. Altman R, Alarcón G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34: 505-514.
21. CASP. Critical appraisal checklists. http://www.casp-uk.net/# !casp-tools-checklists/c18f8 (2014, accessed 5 November 2014).
22. Jonsson H, Helgadottir GP, Aspelund T, et al. Hand osteoarthritis in older women is associated with carotid and coronary atherosclerosis: The AGES Reykjavik study. Ann Rheum Dis 2009; 68: 1696-1700.
23. Reid JL, Morton DJ, Wingard DL, et al. Obesity and other cardiovascular disease risk factors and their association with osteoarthritis in Southern California American Indians, 2002-2006. Ethn Dis 2010; 20: 416-422.
24. Rahman MM, Kopec JA, Anis AH, et al. Risk of cardiovascular disease in patients with osteoarthritis: A prospective longitudinal study. Arthritis Care Res 2013; 65: 1951-1958.
25. Hoeven TA, Kavousi M, Clockaerts S, et al. Association of atherosclerosis with presence and progression of osteoarthritis: The Rotterdam Study. Ann Rheum Dis 2013; 72: 646-651.
26. Tsuboi M, Hasegawa Y, Matsuyama Y, et al. Do musculoskeletal degenerative diseases affect mortality and cause of death after 10 years in Japan? J Bone Miner Metab 2011; 29: 217-223.
27. Walston J, Mcburnie MA, Newman A, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: Results from the Cardiovascular Health Study. Arch Intern Med 2002; 162: 2333-2341.
28. Meek IL, Picavet HS, Vonkeman HE, et al. Increased cardiovascular risk factors in different rheumatic diseases compared with the general population. Rheumatology 2013; 52: 210-216.
29. Nielen MM, van Sijl AM, Peters MJ, et al. Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: A cross-sectional study in primary care. BMC Musculoskelet Disord 2012; 13: 150-150.
30. Ong KL, Wu BJ, Cheung BM, et al. Arthritis: Its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008. Ann Epidemiol 2013; 23: 80-86.
31. Rahman MM, Kopec JA, Cibere J, et al. The relationship between osteoarthritis and cardiovascular disease in a population health survey: A cross-sectional study. BMJ Open 2013; 3: 5-5.
32. Dahaghin S, Bierma-Zeinstra SM, Koes BW, et al. Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Ann Rheum Dis 2007; 66: 916-920.
33. Haugen IK, Ramachandran VS, Misra D, et al. Hand osteoarthritis in relation to mortality and incidence of cardiovascular disease: Data from the Framingham Heart Study. Ann Rheum Dis 2015; 74: 74-81.
34. Inoue R, Ishibashi Y, Tsuda E, et al. Medical problems and risk factors of metabolic syndrome among radiographic knee osteoarthritis patients in the Japanese general population. J Orthop Sci 2011; 16: 704-709.
35. Singh G, Miller JD, Huse DM, et al. Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 2003; 30: 714-719.
36. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012; 380: 2197-2223.
37. Ettinger WH, Davis MA, Neuhaus JM, et al. Long-term physical functioning in persons with knee osteoarthritis from NHANES I: Effects of comorbid medical conditions. J Clin Epidemiol 1994; 47: 809-815.
38. Ettinger WH, Fried LP, Harris T, et al. Self-reported causes of physical disability in older people: The cardiovascular health study. J Am Geriatr Soc 1994; 4: 1035-1044.
39. Fried LP, Bandee-Roche K, Kasper JD, et al. Association of comorbidity with disability in older women: The women's health and ageing study. J Clin Epidemiol 1999; 52: 27-37.
40. Schmidt M,. Cardiovascular risks associated with non-aspirin non-steroidal anti-inflammatory drug use. Dan Med J 2015; 62: pii: B4987-pii: B4987.
41. Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003; 107: 3109-3116.
42. Stubbs B, Hurley M, Smith T,. What are the factors that influence physical activity participation in adults with knee and hip osteoarthritis? A systematic review of physical activity correlates. Clin Rehabil 2015; 29: 80-94.
43. Naci H, Ioannidis JP,. Comparative effectiveness of exercise and drug interventions on mortality outcomes: Metaepidemiological study. BMJ 2013; 347: f5577-f5577.
44. Uthman OA, van der Windt DA, Jordan JL, et al. Exercise for lower limb osteoarthritis: Systematic review incorporating trial sequential analysis and network meta-analysis. BMJ 2013; 347: f5555-f5555.
45. Fifth Joint Task Force of the European Society of Cardiology, European Association of Echolcardiography, European Association of Percutaneous Cardiovascular Interventions, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol 2012; 19: 585-667.
46. Capewell S, O'Flaherty M,. Rapid mortality falls after risk-factor changes in populations. Lancet 2011; 378: 752-753.